Vera Therapeutics, Inc. - Class A Common Stock, $0.001 par value per share (VERA)

Historical Holders from Q2 2021 to Q1 2025

Symbol
VERA on Nasdaq
CUSIP
92337R101
Type / Class
Equity / Class A Common Stock, $0.001 par value per share
Shares outstanding
63M
All holders as of December 31, 2024
Q4 2024
Shares, excl. options
62.9M
Holdings value
$2.66B
% of all portfolios
0.009%
Grand Portfolio weight change
+0.001%
Number of holders
177
Number of buys
118
Number of sells
-59
Average Value change %
+0%
Average buys %
+0.002%
Average sells %
-0.001%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Vera Therapeutics, Inc. - Class A Common Stock, $0.001 par value per share (VERA)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Avoro Capital Advisors LLC 8.9% $135M 5.61M Avoro Capital Advisors LLC Dec 31, 2024

Institutional Holders of Vera Therapeutics, Inc. - Class A Common Stock, $0.001 par value per share (VERA)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q1 87K $2.09M -$150K $24.02 8
2024 Q4 62.9M $2.66B +$390M $42.29 177
2024 Q3 53.5M $2.37B -$1.95M $44.20 172
2024 Q2 53M $1.92B +$58M $36.18 169
2024 Q1 51.3M $2.21B +$452M $43.12 156
2023 Q4 41.3M $636M +$28.9M $15.38 93
2023 Q3 39.3M $538M +$9.59M $13.71 83
2023 Q2 38.1M $612M +$42.6M $16.05 76
2023 Q1 37.4M $290M +$138M $7.76 69
2022 Q4 21.2M $411M -$8M $19.35 56
2022 Q3 21.5M $457M +$21M $21.31 53
2022 Q2 20.4M $277M +$6.51M $13.61 47
2022 Q1 17.4M $408M +$122M $23.49 48
2021 Q4 14M $374M +$10.5M $26.72 36
2021 Q3 14.7M $252M +$4.18M $17.35 31
2021 Q2 14.5M $186M +$186M $13.25 21